Fractyl Health, Inc. Common Stock
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It develops Rejuva, a novel ade… Read more
Market Cap & Net Worth: Fractyl Health, Inc. Common Stock (GUTS)
Fractyl Health, Inc. Common Stock (NASDAQ:GUTS) has a market capitalization of $68.24 Million ($68.24 Million) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #21278 globally and #7634 in its home market, demonstrating a -8.51% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Fractyl Health, Inc. Common Stock's stock price $0.44 by its total outstanding shares 153372044 (153.37 Million).
Fractyl Health, Inc. Common Stock Market Cap History: 2024 to 2026
Fractyl Health, Inc. Common Stock's market capitalization history from 2024 to 2026. Data shows change from $308.28 Million to $68.24 Million (-80.89% CAGR).
Index Memberships
Fractyl Health, Inc. Common Stock is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.20 Trillion | 0.00% | #578 of 976 |
|
NASDAQ Composite
IXIC
|
$32.97 Trillion | 0.00% | #1902 of 3165 |
Weight: Fractyl Health, Inc. Common Stock's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Fractyl Health, Inc. Common Stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Fractyl Health, Inc. Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3314.82x
Fractyl Health, Inc. Common Stock's market cap is 3314.82 times its annual revenue
1740.90x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $308.28 Million | $93.00K | -$68.69 Million | 3314.82x | N/A |
Competitor Companies of GUTS by Market Capitalization
Companies near Fractyl Health, Inc. Common Stock in the global market cap rankings as of March 19, 2026.
Key companies related to Fractyl Health, Inc. Common Stock by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #165 globally with a market cap of $114.33 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #285 globally with a market cap of $73.32 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #340 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #497 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $114.33 Billion | $451.59 |
| #285 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.32 Billion | $744.12 |
| #340 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #497 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Fractyl Health, Inc. Common Stock Historical Marketcap From 2024 to 2026
Between 2024 and today, Fractyl Health, Inc. Common Stock's market cap moved from $308.28 Million to $ 68.24 Million, with a yearly change of -80.89%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $68.24 Million | -79.78% |
| 2025 | $337.42 Million | +9.45% |
| 2024 | $308.28 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Fractyl Health, Inc. Common Stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $68.24 Million USD |
| MoneyControl | $68.24 Million USD |
| MarketWatch | $68.24 Million USD |
| marketcap.company | $68.24 Million USD |
| Reuters | $68.24 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.